High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors2000 · 180 citations
2. 2Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection2004 · 527 citations
3. 3Pharmacokinetic Interaction Between Nevirapine and Rifampicin in HIV-Infected Patients With Tuberculosis2001 · 142 citations
4. 4Pharmacokinetics and Tolerability of a Higher Rifampin Dose versus the Standard Dose in Pulmonary Tuberculosis Patients2007 · 185 citations
5. 5The Tablet Formulation of Lopinavir/Ritonavir Provides Similar Bioavailability to the Soft-Gelatin Capsule Formulation With Less Pharmacokinetic Variability and Diminished Food Effect2007 · 154 citations